pharmaceutical M&A

Since 2023, the pharmaceutical industry has intensified its commitment to artificial intelligence (AI) to revolutionize drug discovery. The world's 10 largest pharma companies are actively collaborating with AI-specialized startups while developing their own AI-powered discovery engines. This dual strategic movement reflects a unanimous awareness: AI can transform a costly and lengthy process into a faster,...